Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling.
Ingrid E H KremerSilvia M A A EversPeter J JongenMickaël HiligsmannPublished in: Health expectations : an international journal of public participation in health care and health policy (2017)
This study suggests that, overall, neurologists and nurses regard the same DMD attributes as important as MS patients with the notable exception of safety. This study provides valuable information for the development of interventions to support shared decision making and highlights which attributes of DMDs may need additional attention.